Clinicopathologic studies report elevated nuclear YAP1 in the tumor stroma of more aggressive prostate cancers, including cases with lymph node metastasis or seminal vesicle invasion. Here, YAP1 is linked to metastatic malignant neoplasm in the lymph nodes.